Literature DB >> 1624609

The cyanide poisoning necropsy: an appraisal of risk factors.

A R Forrest1, J H Galloway, D N Slater.   

Abstract

Blood cyanide concentrations were measured in samples obtained from a pathologist before and after carrying out a necropsy on the body of a victim of cyanide poisoning. There was no significant increase in his blood cyanide concentration after carrying out the procedure. It is suggested that an important factor in determining the risk to those carrying out necropsies of the bodies of victims of cyanide poisoning is the amount of cyanide remaining in the stomach. There are several ways in which the theoretical risk inherent in carrying out such necropsies could be reduced, such as the use of a full face respirator, or the removal, intact, of the upper gastrointestinal tract to a fume cupboard for examination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624609      PMCID: PMC495238          DOI: 10.1136/jcp.45.6.544

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Increase in severity of graft versus host disease by cytomegalovirus.

Authors:  A L McCarthy; J S Malik Peiris; C E Taylor; M A Green; L Sviland; A D Pearson; A J Malcolm
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  The biohazard potential of cyanide poisoning during postmortem examination.

Authors:  J M Andrews; E S Sweeney; T C Grey; T Wetzel
Journal:  J Forensic Sci       Date:  1989-09       Impact factor: 1.832

  2 in total
  3 in total

Review 1.  Health and safety at necropsy.

Authors:  J L Burton
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Risk of inhaling cyanide during necropsy examination.

Authors:  G C Fernando
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

Review 3.  Management of chemically contaminated bodies.

Authors:  Adrienne Edkins; Virginia Murray
Journal:  J R Soc Med       Date:  2005-04       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.